Prescribers’ satisfaction with delivering medications for opioid use disorder

BACKGROUND: Expanding access to medications for opioid use disorder (MOUD), such as buprenorphine and extended release (XR) naltrexone, is critical to addressing the US opioid epidemic, but little is known about prescriber satisfaction with delivering these two types of MOUD. The current study descr...

Descripción completa

Detalles Bibliográficos
Autores principales: Knudsen, Hannah K., Brown, Randy, Jacobson, Nora, Horst, Julie, Kim, Jee-Seon, Kim, Hanna, Madden, Lynn M., Haram, Eric, Molfenter, Todd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521499/
https://www.ncbi.nlm.nih.gov/pubmed/34663379
http://dx.doi.org/10.1186/s13011-021-00413-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521499/
https://www.ncbi.nlm.nih.gov/pubmed/34663379
http://dx.doi.org/10.1186/s13011-021-00413-7

Ejemplares similares